Global Adjustable Gastric Banding Market, By Type (Lap-Band, Realize Band), By Application, and By Region - Trends and Forecast Analysis, 2021-2035

Global Adjustable Gastric Banding Market Size is expected to reach USD 22.2 Billion by 2035 from USD 4.07 Billion in 2024, with a CAGR of around 16.65% between 2024 and 2035. ​Leading pharmaceutical companies have been advancing acute myeloid leukemia (AML) therapeutics through innovative treatments and strategic collaborations. Bristol-Myers Squibb has developed Onureg, an oral hypomethylating agent approved for continued treatment in AML patients in first remission, aiming to prolong overall survival and reduce relapse risk. Novartis has focused on targeted therapies, with midostaurin receiving Breakthrough Therapy designation for newly diagnosed FLT3-mutated AML, marking a significant step in personalized medicine. Genmab has been exploring novel antibody-based treatments, such as GEN3014, a HexaBody-CD38 monoclonal antibody showing potent anti-tumor activity in hematologic malignancies. Roche has continued its commitment to oncology by developing therapies that target specific genetic mutations associated with AML, enhancing treatment efficacy. GlaxoSmithKline Pharmaceuticals has invested in research to develop innovative treatments for hematologic cancers, contributing to the evolving landscape of AML therapeutics. These developments reflect a broader trend towards personalized medicine, with companies focusing on therapies tailored to individual genetic profiles, improving patient outcomes and offering new hope in AML treatment.​

Driver: Obesity Surge and Surgical Advancements Drive Market

The global adjustable gastric banding market has been driven by two key factors. The increasing prevalence of obesity has led to a higher demand for weight-loss surgeries. In countries like the United States, the rising obesity rates have resulted in more individuals seeking surgical interventions for weight management. Technological advancements in surgical techniques have improved the safety and effectiveness of adjustable gastric banding procedures. For instance, the development of bands that can be adjusted remotely has enhanced patient convenience and reduced the need for multiple follow-up visits. However, the market faces a significant restraint in the form of band-related complications. Issues such as band slippage or erosion may require reoperation, impacting patient satisfaction and overall market growth. Despite this, opportunities exist in emerging markets where the prevalence of obesity is increasing rapidly. Countries like China and India are witnessing a surge in demand for weight-loss procedures due to rising disposable incomes and changing lifestyles. Additionally, technological innovations in adjustable gastric banding devices present opportunities for market growth. The integration of smart technology in gastric bands, such as sensors and connectivity, can enhance patient experience and disease management, making these devices more appealing to a tech-savvy consumer base.​

Key Insights:

• The adoption rate of adjustable gastric banding (AGB) has declined over recent years, with the procedure now constituting about 56% of bariatric surgeries in some established clinics.

• In a large UK cohort, 2246 patients underwent AGB between 2004 and 2014, with a re-operation rate for complications of 4.2% over 9 years and an explantation rate of 1.5%.

• Long-term follow-up studies show that up to 52.2% of gastric bands may require removal within 10 years due to complications or insufficient weight loss.

• The mean excess weight loss after 12 years or longer post-AGB is approximately 42.8%, based on follow-up data from over half of patients.

• Adjustable gastric bands accounted for about 86.1% of the gastric bands market share in 2024, reflecting strong preference for their flexibility and adjustability.

Segment Analysis:

The adjustable gastric banding market is segmented by type into Lap-Band and Realize Band, and by application into hospitals and clinics. Lap-Band, a well-known adjustable gastric band, has been widely used due to its ease of placement and the ability to adjust it post-surgery for optimal weight loss. For example, a 35-year-old patient undergoing surgery at a major hospital opted for the Lap-Band to address obesity. The procedure was done under laparoscopic guidance, and the patient was able to adjust the band as required during follow-up visits. The Realize Band, on the other hand, has gained popularity due to its advanced features, such as a wider band and a more gradual adjustment process, offering potentially smoother weight loss results. In a private clinic, a patient with a BMI of 40 was offered the Realize Band for its precision in controlling weight loss over time. The application of these bands occurs predominantly in hospitals and clinics, where patients receive detailed pre-operative counseling and post-operative care. Hospitals offer comprehensive care for patients with more complex health conditions, while clinics are preferred by those seeking less intensive care. For instance, a clinic in a suburban area was able to provide quick follow-ups and personalized care for patients using these bands, offering both convenience and specialized attention.

Regional Analysis:

The adjustable gastric banding market has seen diverse growth across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In North America, where obesity rates are high, hospitals are increasingly performing gastric banding surgeries. A 50-year-old male in the U.S. recently underwent a Lap-Band procedure to address his obesity-related health issues, benefiting from advanced post-operative care. In Europe, countries like Germany have incorporated adjustable gastric banding as a part of their national healthcare services. A clinic in Paris specializes in offering both Lap-Band and Realize Band options to patients seeking weight-loss solutions. Asia-Pacific has experienced rapid growth due to rising obesity rates in countries like China and India, where people are becoming more aware of the health risks associated with obesity. In a clinic in India, a young patient received a Realize Band for weight loss, seeing significant improvements over a year. Latin America has embraced these procedures as well, with clinics in Brazil increasingly performing gastric banding surgeries as the middle class expands. The Middle East & Africa, despite facing healthcare infrastructure challenges, has seen an uptick in demand. A clinic in Dubai recently conducted gastric banding surgeries, helping several patients manage their weight more effectively, demonstrating a shift towards addressing obesity-related health issues in the region.

Competitive Scenario:

​The adjustable gastric banding market has experienced significant developments with contributions from key industry players. Apollo Endosurgery has advanced the field by publishing the MERIT study in The Lancet, demonstrating the effectiveness of its Endoscopic Sleeve Gastroplasty (ESG) procedure. This minimally invasive technique has shown promising results in weight loss and improvement in obesity-related comorbidities. Ethicon, a subsidiary of Johnson & Johnson, discontinued its Realize Band in 2016 due to declining popularity and high complication rates, such as band slippage and erosion . In contrast, Helioscopie's Heliogast HAGA band features a double balloon design for enhanced stability and a 360° accessible port, aiming to reduce complications and improve patient outcomes . MID Medical Innovation Developpement offers the MIDBAND™, a latex-free, adjustable gastric band designed for laparoscopic implantation. Its low-pressure adjustment system and reversible nature make it a less invasive option with potential for future surgical interventions . Cousin Biotech has introduced the Cousin Gastric Band, focusing on patient comfort and ease of adjustment. These innovations reflect a shift towards more personalized and less invasive bariatric solutions, catering to the evolving needs of patients seeking effective weight-loss interventions.​

Adjustable Gastric Banding Market Report Scope

The Global Adjustable Gastric Banding Market report is segmented as follows:

By Type,

• Lap-Band
• Realize Band

By Application,

• Hospitals
• Clinics

By Region,

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Spain
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Southeast Asia
• Rest of Asia Pacific
• Latin America
• Brazil
• Argentina
• Rest of Latin America
• Middle East & Africa
• Saudi Arabia
• UAE
• South Africa
• Rest of Middle East and Africa

Key Market Players,

• Apollo Endosurgery
• Ethicon (Johnson & Johnson)
• Helioscopie (Sante Actions Group)
• MID (Medical Innovation Developpement)
• Cousin Biotech

Research Objectives

• Proliferation and maturation of trade in the global Adjustable Gastric Banding Market.
• The market share of the global Adjustable Gastric Banding Market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Adjustable Gastric Banding Market.
• Feasibility study, new market insights, company profiles, investment return, market size of the global Adjustable Gastric Banding Market.